unknown
Stage
1
Investors
About
Veloxis Pharmaceuticals is a global specialty pharmaceutical company focused on developing therapies and programs to improve the lives of transplant and immunocompromised patients. It is a part of Asahi Kasei Corporation and specializes in transplant medicine innovation.
Explore Veloxis Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.